CX3CR1 Receptor Polymorphisms, Th1 Cell Recruitment, and Acute Myocardial Infarction Outcome: Looking for a Link
Open Access
- 7 November 2013
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-9
Abstract
Fractalkine is a proinflammatory chemokine that participates in atherosclerotic process mediating the interactions of vascular cells and leukocytes and selective recruitment of Th1 lymphocytes, through interaction with CX3CR1 receptor. The polymorphism of the fractalkine receptor 280M-containing haplotype, which codifies for a receptor with minor expression and with a reduced binding capability, represents a novel protective factor of atherosclerotic disease. We investigated the association among CX3CR1 genotype, the inflammatory infiltrate subpopulations recruited in the plaque, and the in situ expression of fractalkine and its receptor, in patients who died of myocardial infarction (AMI) compared with subjects who died of noncardiac causes. Patients with nonlethal AMI (AMI survivors) were also investigated to correlate the CX3CR1 polymorphisms and the incidence of lethal AMI. A strong T cells infiltrate was found in infarct related artery (IRA) plaques of AMI patients presenting the V249T280haplotype (84%). Conversely, a decreased T cell recruitment was associated with I249T280haplotype in the controls (64%). The significant higher presence of the variant allele I249 in homo- and heterozygosis, found in controls (91%) and in AMI survivors (94%), with respect to the patients who died of AMI (48%), showed the relevance of this polymorphism both in the onset and outcome of acute myocardial infarction. The presence of CX3CR1 polymorphisms could influence the incidence and the outcome of acute myocardial infarction, altering the inflammation of the whole coronary tree by the impaired recruitment of Th1 polarized subpopulation in the coronary plaque.Keywords
This publication has 27 references indexed in Scilit:
- Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1PLOS ONE, 2012
- The immune system in atherosclerosisNature Immunology, 2011
- Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin TherapyArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Diffuse and Active Inflammation Occurs in Both Vulnerable and Stable Plaques of the Entire Coronary TreeJACC, 2005
- Fractalkine, a CX3C‐chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP‐1Immunology & Cell Biology, 2001
- Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responsesJournal of Clinical Investigation, 2001
- Down‐regulation of α6 integrin, an anti‐oncogene product, by functional cooperation of H‐Ras and c‐MycGenes to Cells, 2001
- Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseBlood, 2001
- Chemokine Receptors and Their Role in Vascular BiologyJournal of Vascular Research, 2000
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997